Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Study on the Compensatory Mechanism of Iodine Nutrition and the Optimal Intake Level of Lactating Women

9. august 2020 oppdatert av: Wanqi Zhang, Tianjin Medical University
Due to the lack of direct evidence of optimal iodine intake of Chinese children, pregnant and lactating women and infants were found during the recent revision of Chinese dietary reference intakes (DRIs) of iodine in 2013 by the applicant Pro. Zhang, and no systematical research about compensatory mechanism of iodine nutrition in lactating women was found yet. Previous study funded by United Nations International Children's Emergency Fund (UNICEF) cooperated with the international experts on iodine and key project of national natural science foundation of China under the guidance of Pro. Zhang, had obtained the safe intake range of iodine from children and pregnant women, more than 10 joint papers were published, which laid the foundation of population study and international cooperation.

Studieoversikt

Status

Rekruttering

Intervensjon / Behandling

Detaljert beskrivelse

Studies indicate lactating women and their infants are the most vulnerable population to the adverse effects of iodine deficiency and excess, and because of the complexity of the study of lactating mothers and infants and the difficulty of sample collection, it is proposed to overcome this problem with the help of the advanced dried blood spot technique and iodine balance study method from the panel of Iodine Global Network (IGN). Investigators intend to recruit 900 late pregnant women in Tianjin, Hebei and Shandong;then establishing a dynamic cohort of breastfeeding mother-infant to 6 months after delivery to investigate the physiological compensatory mechanism of iodine nutrition in lactating women with the combination of animal experiment; On the other hand, 180 exclusively breastfeeding mother and infants within postpartum 0-6 months, will be selected to participate the iodine balance study.

Optimized method of iodine balance experiment of infants by both foreign partner and Pro. Zhang's team will be adopted to obtain the first iodine balance value of Chinese lactating women and infants,providing the direct evidence for the revision of DRIs in lactating women and infants, and guide the lactating women proper iodine supplementation to meet the requirements of both mothers and infants.

Studietype

Observasjonsmessig

Registrering (Forventet)

600

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studer Kontakt Backup

Studiesteder

    • Massachusetts
      • Boston, Massachusetts, Forente stater, 02101-02117
        • Rekruttering
        • Boston University School of Medicine; Iodine Global Network (IGN)
        • Ta kontakt med:
      • Beijing, Kina
        • Rekruttering
        • Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention
        • Ta kontakt med:
        • Ta kontakt med:
      • Shandong, Kina
        • Rekruttering
        • Shandong Institute of Endemic Disease Control and Prevention
        • Ta kontakt med:
        • Ta kontakt med:
      • Zurich, Sveits
        • Rekruttering
        • Swiss federal institute of Technology (ETH)
        • Ta kontakt med:
        • Underetterforsker:
          • Maria Andersson

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

1 dag til 40 år (Barn, Voksen)

Tar imot friske frivillige

Ja

Kjønn som er kvalifisert for studier

Alle

Prøvetakingsmetode

Ikke-sannsynlighetsprøve

Studiepopulasjon

Women in the third trimester (18-40 years old), lactating women (38-42 weeks of gestation) and infants (0-6 months), all from Tianjin, Hebei and Shandong

Beskrivelse

Inclusion Criteria:

  • Women in their third trimester:⑴Aged 18-40, who have lived in the area for 1 year;⑵Single pregnancy;⑶Those who have no special dietary habits;
  • Lactating woman:⑴Breastfeeding a child;⑵Normal thyroid function during pregnancy;⑶Term delivery (38-42 weeks of gestation);
  • Infants and young children:⑴0-6 months;⑵Breastfeeding;⑶Full term (38-42 weeks of gestation);⑷Normal birth weight (2500-4000g);⑸The thyroid-stimulating hormone (TSH) value of heel blood was normal;⑹Apgar score 8.

Exclusion Criteria:

  • Women in their third trimester:⑴Smoking or drinking;⑵Iodized drugs or contrast agents have been used in the past year;⑶A history of thyroid disease, autoimmune disease, endocrine disease, heart disease, chronic disease or family hereditary disease, etc;
  • Lactating woman:⑴A history of thyroid disease, autoimmune disease, endocrine disease, heart disease, chronic disease or family hereditary disease, etc;
  • Infants and young children:⑴Have pathological jaundice, autoimmune disease, congenital heart disease and other diseases.

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Disposable random urine
Tidsramme: baseline
μg/L
baseline
Venous blood
Tidsramme: baseline
μg/L
baseline
Water iodine intake
Tidsramme: baseline
μg/day
baseline
Salt iodine concentration
Tidsramme: baseline
μg/day
baseline
Colostrum
Tidsramme: 1 week
μg/L
1 week
Mother and child urine randomly at one time
Tidsramme: 1 week
μg/L
1 week
Neonatal heel blood
Tidsramme: 1 week
μg/L
1 week
Thyroglobulin(TG)
Tidsramme: 1 week
ug/L
1 week
Thyroid-stimulating hormone
Tidsramme: 1 week
mIU/L
1 week
Infant disposable random urine
Tidsramme: 4 weeks
μg/L
4 weeks
Infant disposable random urine
Tidsramme: 24 weeks
μg/L
24 weeks
Infant disposable random urine
Tidsramme: 12 weeks
μg/L
12 weeks
24 h urine
Tidsramme: 4 weeks
μg/L
4 weeks
24 h urine
Tidsramme: 12 weeks
μg/L
12 weeks
24 h urine
Tidsramme: 24 weeks
μg/L
24 weeks
Urinary iodine excretion
Tidsramme: 4 weeks
μg/day
4 weeks
Urinary iodine excretion
Tidsramme: 12 weeks
μg/day
12 weeks
Urinary iodine excretion
Tidsramme: 24 weeks
μg/day
24 weeks
Milk output
Tidsramme: 4 weeks
μg/day
4 weeks
Milk output
Tidsramme: 12 weeks
μg/day
12 weeks
Milk output
Tidsramme: 24 weeks
μg/day
24 weeks
Milk iodine excretion
Tidsramme: 4 weeks
μg/day
4 weeks
Milk iodine excretion
Tidsramme: 12 weeks
μg/day
12 weeks
Milk iodine excretion
Tidsramme: 24 weeks
μg/day
24 weeks
Average iodine intake
Tidsramme: 4 weeks
μg/day
4 weeks
Average iodine intake
Tidsramme: 12 weeks
μg/day
12 weeks
Average iodine intake
Tidsramme: 24 weeks
μg/day
24 weeks
Thyroid volume
Tidsramme: 1 week
cm³
1 week
Thyroid volume
Tidsramme: 4 weeks
cm³
4 weeks
Thyroid volume
Tidsramme: 12 weeks
cm³
12 weeks
Thyroid volume
Tidsramme: 24 weeks
cm³
24 weeks
Thyroid nodule
Tidsramme: 1 week
cm³
1 week
Thyroid nodule
Tidsramme: 4 weeks
cm³
4 weeks
Thyroid nodule
Tidsramme: 12 weeks
cm³
12 weeks
Thyroid nodule
Tidsramme: 24 weeks
cm³
24 weeks
Dried blood spot(DBS)
Tidsramme: 3 days
μg/L
3 days
Dried blood spot(DBS)
Tidsramme: 12 weeks
μg/L
12 weeks
Diet iodine intake
Tidsramme: 1 week
μg/day
1 week
Fecal iodine excretion
Tidsramme: 1 week
μg/day
1 week

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Etterforskere

  • Hovedetterforsker: ZiYun Pan, Tianjin Medical University
  • Hovedetterforsker: JianQiang Lai, Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention
  • Hovedetterforsker: XueSong Wang, Shandong Institute of Endemic Disease Control and Prevention
  • Hovedetterforsker: YiFan Duan, Institute of Nutrition and Health, Chinese Center for Disease Control and Prevention
  • Hovedetterforsker: GuiJun Tan, Tianjin Medical University
  • Hovedetterforsker: Wen Chen, Tianjin Medical University
  • Hovedetterforsker: YanTing Chen, Tianjin Medical University
  • Hovedetterforsker: Min Gao, Tianjin Medical University
  • Studiestol: Michael B Zimmermann, doctorate, Swiss federal institute of Technology (ETH)
  • Studiestol: Elizabeth N Pearce, doctorate, Boston University School of Medicine; Iodine Global Network (IGN)
  • Studiestol: Maria Andersson, doctorate, Swiss federal institute of Technology (ETH); Iodine Global Network (IGN)

Publikasjoner og nyttige lenker

Den som er ansvarlig for å legge inn informasjon om studien leverer frivillig disse publikasjonene. Disse kan handle om alt relatert til studiet.

Generelle publikasjoner

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

1. januar 2020

Primær fullføring (Forventet)

31. desember 2021

Studiet fullført (Forventet)

31. desember 2024

Datoer for studieregistrering

Først innsendt

21. juli 2020

Først innsendt som oppfylte QC-kriteriene

27. juli 2020

Først lagt ut (Faktiske)

30. juli 2020

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

11. august 2020

Siste oppdatering sendt inn som oppfylte QC-kriteriene

9. august 2020

Sist bekreftet

1. august 2020

Mer informasjon

Begreper knyttet til denne studien

Plan for individuelle deltakerdata (IPD)

Planlegger du å dele individuelle deltakerdata (IPD)?

NEI

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere